Your professional development is critical to the care of your patients. Stay on top of the latest treatments and information with ReachMD's CME activities. Our topics span cardiology, diabetes, oncology, women's health and more. And our CME library is continuously growing, every quarter.
Recognizing and diagnosing heart failure in patients with HCM
Recognizing and diagnosing heart failure in patients with HCM
Multiple Myeloma Care: Translating Evolving Practices to Oncology Nurses in Community Settings
Multiple Myeloma Care: Translating Evolving Practices to Oncology Nurses in Community Settings
KOL KNOCKOUT™: Endocrinology Edition – Challenging Cases of Thyroid Eye Disease
KOL KNOCKOUT™: Endocrinology Edition – Challenging Cases of Thyroid Eye Disease
Optimal pharmacological management of HCM by clinical manifestations
Optimal pharmacological management of HCM by clinical manifestations
KOL KNOCKOUT™: Oculoplastics Edition – Sculpting Sight For Patients With Thyroid Eye Disease - Round 1
KOL KNOCKOUT™: Oculoplastics Edition – Sculpting Sight For Patients With Thyroid Eye Disease - Round 1
From Trial to Treatment: Translating Emerging Clinical Data into Meaningful Schizophrenia Clinical Care
From Trial to Treatment: Translating Emerging Clinical Data into Meaningful Schizophrenia Clinical Care
Tailoring Your Perioperative Immunotherapy Approach for Resectable NSCLC
Tailoring Your Perioperative Immunotherapy Approach for Resectable NSCLC
Stratified Care: The Role of Switching or Augmentation Therapies Used When Treating Schizophrenia
Stratified Care: The Role of Switching or Augmentation Therapies Used When Treating Schizophrenia
Exploring the Spectrum of Efficacy in Emerging Schizophrenia Therapies: From Positive to Negative to Cognitive Symptoms
Exploring the Spectrum of Efficacy in Emerging Schizophrenia Therapies: From Positive to Negative to Cognitive Symptoms
D2 Antagonists Limitations and Challenges: A New Era in Schizophrenia Pathophysiology
D2 Antagonists Limitations and Challenges: A New Era in Schizophrenia Pathophysiology
When Adjuvant Immunotherapy for Resectable NSCLC May Be the Better Approach
When Adjuvant Immunotherapy for Resectable NSCLC May Be the Better Approach
Perioperative Immunotherapy for Resectable NSCLC: Evaluating Approved and Emerging Approaches
Perioperative Immunotherapy for Resectable NSCLC: Evaluating Approved and Emerging Approaches
